Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| Ramipril efficacy in slowing CKD progression enhanced in obese subjects. |
|
|
| EurekAlert: Ramipril lowered the risk of progression to ESRD in all three weight groups. However, the magnitude of risk reduction was much greater for obese patients: 86 percent, compared to 45 percent in normal-weight patients. Thus, obese patients taking ramipril exhibited about the same ESRD risk as normal-weight patients. |
Professional dialysis recruitment

